BioSpace: FDA Approves First One-time Cell Therapy for a Solid Tumor

By Gail Dutton Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic...

By Jane Koo The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between...

How a strategic, collaborative approach can accelerate product development and bring cell therapies to patients Jason Bock, Ph.D. Access the...